Plastic Surgery Challenges in War Wounded II: Regenerative Medicine. 2016

Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
Division of Burn, Wound, and Trauma, Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, Ohio.; Department of Plastic and Reconstructive Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland.

Background: A large volume of service members have sustained complex injuries during Operations Iraqi Freedom (OIF) and Enduring Freedom (OEF). These injuries are complicated by contamination with particulate and foreign materials, have high rates of bacterial and/or fungal infections, are often composite-type defects with massive soft tissue wounds, and usually have multisystem involvement. While traditional treatment modalities remain a mainstay for optimal wound care, traditional reconstruction approaches alone may be inadequate to fully address the scope and magnitude of such massive complex wounds. As a result of these difficult clinical problems, the use of regenerative medicine therapies, such as autologous adipose tissue grafting, stem cell therapies, nerve allografts, and dermal regenerate templates/extracellular matrix scaffolds, is increased as adjuncts to traditional reconstructive measures. Basic and Clinical Science Advances: The beneficial applications of regenerative medicine therapies have been well characterized in both in vitro studies and in vivo animal studies. The use of these regenerative medicine techniques in the treatment of combat casualty injuries has been increasing throughout the recent war conflicts. Clinical Care Relevance: Military medicine has shown positive results when utilizing certain regenerative medicine modalities in treating complex war wounds. As a result, multi-institution clinical trials are underway to further evaluate these observations and reconstruction measures. Conclusion: Successful combat casualty wound care often requires a combination of traditional aspects of the reconstructive ladder/elevator with adoption of various regenerative medicine therapies. Due to the recent OIF/OEF conflicts, a high volume of combat casualties have benefited from adoption of regenerative medicine therapies and increased access to innovative clinical trials. Furthermore, many of these patients have had long-term follow-up to report on clinical outcomes that substantiate current treatment paradigms and concepts within regenerative medicine, reconstructive, and rehabilitation care. These results are applicable to not only combat casualty care but also to nonmilitary patients.

UI MeSH Term Description Entries

Related Publications

Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
May 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
June 2014, Plastic and reconstructive surgery,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
November 1946, Plastic and reconstructive surgery (1946),
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
April 1946, Annals of surgery,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
April 1946, Annals of surgery,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
January 1946, Transactions of the Southern Surgical Association. Southern Surgical Association (U.S.),
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
September 2016, JAMA facial plastic surgery,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
January 2010, Cell transplantation,
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
February 1947, Statistical bulletin (Metropolitan Life Insurance Company),
Ian L Valerio, and Jennifer M Sabino, and Christopher L Dearth
May 2006, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!